AzTrials
AzTrials

PrematureNCT07113535

Post-extubation Use RAM Cannula Versus Short Binasal Prong Interfaces in Preterm Infants

A study testing RAM cannula and Short binasal prong in people with Premature and Respiratory Distress Syndrome, run by Ministry of Health, Saudi Arabia at 1 site in Saudi Arabia.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

Nowadays, the use of non-invasive ventilation for preterm infants in the NICU has increased to avoid complications associated with prolonged endotracheal intubation. Adequate pressure delivery through non-invasive ventilation is essential, as it enhances the growth and development of premature lungs. Read more about this study

Who is it for?
Ages 24 hours to 28 days
What is being tested?
RAM cannula and Short binasal prong
Could I receive a placebo?
No, everyone receives an active treatment
How many people
90 participants
Where
1 siteSaudi Arabia
Study dates
Aug 2025to 31 Dec 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 24 hours to 28 days
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Inborn preterm neonates ≤ 32 weeks of gestational and/or birth weight ≤1500 g with respiratory distress syndrome requiring initial invasive ventilation support for at least 24 hours.

Who cannot join

  • Outborn preterm neonates
  • Major congenital malformations.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Ohoud Almoualled, Dr contact

+966500550679

o.doc2or@gmail.com

Nehad Nasef, Dr contact

Saudi Arabia1 site
  • King Salman Bin Abdulaziz Medical City

    Madinah

Other trials in Saudi Arabia

About this study

Official title: RAM Cannula Versus Short Binasal Prong Interfaces of Non- Invasive Ventilation for Prevention of Extubating Failure in Preterm Infants: A Randomized Controlled Trial

Nowadays, the use of non-invasive ventilation for preterm infants in the NICU has increased to avoid complications associated with prolonged endotracheal intubation. Adequate pressure delivery through non-invasive ventilation is essential, as it enhances the growth and development of premature lungs. Various interfaces have been used to ensure proper sealing. The RAM cannula, used as an interface for non-invasive respiratory support in preterm neonates, is associated with reduced nasal trauma compared to short binasal prongs (SBPs), due to its softer material, making it a safer option. However, the RAM cannula has been shown to deliver lower pharyngeal pressure and, therefore, may not maintain airway pressure as consistently as nasal prongs. Currently, limited data is available regarding the efficacy of nasal prongs compared to the RAM cannula as a post-extubation interface for non-invasive ventilation support in preterm infants. Additionally, we have observed that the use of the RAM cannula for non-invasive ventilation in preterm infants is associated with a longer duration of oxygen therapy compared to SBPs.

The investigators hypothesize that the RAM cannula provides a lower level of positive end-expiratory pressure compared to SBPs during non-invasive ventilation.

The investigators aim to assess the efficacy and safety of the RAM cannula versus SBPs as nasal interfaces for post-extubation non-invasive respiratory support in preterm infants.

Read the detailed description

Preterm infants will be randomized to receive post-extubation non invasive respiratory support either through RAM cannula or SBPs. Neonates in both groups will be uniformly managed as per unit protocol as following:

Extubation criteria :

  • Birth weight < 1000 gram :MAP <7 cmH2O and FIO2 <0.30
  • Birth weight>1000 gram :MAP >8 cmH2O and FIO2 <0.30

Re intubation criteria :

  • FIO2>0.60 to maintain SaO2 >88% OR PaO2 > 45 mmHg
  • PaCO2 {arterial} > 55-60 with PH < 7.25
  • Apnea and requiring bag and mask ventilation
  • Evidence of increased work of breathing {retractions -grunting -chest wall distortion } plus abnormal chest x ray
Being tested
RAM cannula, Short binasal prong
Keywords
nasal interface, noninvasive respiratory support, premature, RAM cannula, Chest ultrasound, Diaphragm
Medical subject headings
Premature Birth, Respiratory Distress Syndrome

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • RAM cannulaOther

    RAM cannula as an interface for non invasive ventilation in preterm newborns

  • Short binasal prongOther

    Short binasal prong as an interface for non invasive ventilation in preterm newborns

Study groups in NCT07113535
Study groupRoleWhat they receive
RAM cannula groupActive comparatorPreterm infants will receive non-invasive ventilation by RAM cannula
Receives: Other: RAM cannula
Short binasal prong groupActive comparatorPreterm infants will receive non-invasive ventilation by short binasal prongs
Receives: Other: Short binasal prong

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Failure of extubation incidence rate

    Need for reintubation within 72 hours post-extubation trial

    Measured: 28 days of an infant's life

Secondary outcomes (6)
  1. Duration of non-invasive ventilation

    Days on non-invasive ventilation

    Measured: 120 days

  2. whole duration of oxygen therapy

    Days on oxygen therapy during NICU admission

    Measured: 120 days

  3. Diaphragmatic indices and lung ultrasound scores post-extubation (pre & post extubation then weekly)

    Diaphragmatic indices (diaphragmatic thickness \&excursion) and lung ultrasound scores post-extubation

    Measured: 120 days

  4. Need for reintubation within 7 days

    Need for reintubation within 72 hours post-extubation trial

    Measured: 28 days of an infant's life

  5. Bronchopulmonary dysplasia

    Measured: 120 days

  6. Mortality

    Pre-discharge mortality

    Measured: 120 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Aug 2025
  2. Study startAug 2025 (estimated)
  3. Primary completion30 Jun 2027 (estimated)
  4. Study completion31 Dec 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
90 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07113535
Sponsor's protocol ID
H-03-M-11
Status last verified
Aug 2025
First submitted
28 Jul 2025
Last updated
8 Aug 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Data obtained through this study may be provided to qualified researchers for research and scientific purposes (i.e conduction of meta-analysis or systematic review). Data or samples shared will be coded, with no protected health information included. Approval of the request and execution of all applicable agreements (i.e. a material transfer agreement) are prerequisites to the sharing of data with the requesting party.

Publications

  • Gokce IK, Kaya H, Ozdemir R. A randomized trial comparing the short binasal prong to the RAM cannula for noninvasive ventilation support of preterm infants with respiratory distress syndrome. J Matern Fetal Neonatal Med. 2021 Jun;34(12):1868-1874. doi: 10.1080/14767058.2019.1651268. Epub 2019 Aug 8.

    PubMed 31394948

Questions about this trial

What is this clinical trial studying?

A study testing RAM cannula and Short binasal prong in people with Premature and Respiratory Distress Syndrome, run by Ministry of Health, Saudi Arabia at 1 site in Saudi Arabia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 8 Aug 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Saudi Arabia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Ohoud Almoualled, Dr (+966500550679, o.doc2or@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Failure of extubation incidence rate (time frame: 28 days of an infant's life). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07113535, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Aug 2025; AzTrials last refreshed its copy on 26 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in